Mattioli _ultrapeel ii-tranderm.cdr
Ultrapeel ® II plus Transderm ® Meso ® System is a powered
drug-delivery system that has been FDA approved for the
FDA cleared as alternative to injections.
“local administration of ionic drug solutions into the body formedical purposes and can be used as an alternative to injec-
Ultrapeel® Transderm® Meso® System uses Dermoelectro-
Current delivery perception protected.
poration® Technology to deliver any active ingredient into thebody and when connected to Ultrapeel® microdermabrader
Control on homogeneous drug delivery.
allows a very efficient transdermal delivery of products.
Real time skin impedance measurement feature.
Ultrapeel ® II plus Transderm ® Meso ® System is made of the
Real time transdermal delivery monitoring.
• Ultrapeel® II plus digitally controlled microdermabrader
to be delivered and time of treatment.
• Transderm® Meso® delivery display w/applicator
• Super Precision Liquid Dispenser - Super PLD
or particular preparations / Additional terminals.
15.000 Dalton) previously nottransdermally deliverable by
Reproducibility of dose delivered by means
now successfully deliverabledue this outstanding Dermo-
• Hyperhidrosys• Cellulite treatments
derm® Meso® System due to the very high comfortable ses-
• Wrinkles treatments• Fat Deposits treatments
sions. Vibration feature that makes electrical pulses delivery
perception to decrease significantly.
• Pre and post plastic surgery sessions• Skin Whitening treatments
Ultrapeel® Transderm® Meso® System ensure speed of action,
easier regulation of either Current delivery and vibration and
monitors Skin impedance in Real time to give users the final
results they expect. The light applicators allow users to work
greatly for any skin condition and any length of treatment.
Some deliverable drugs • Type A Botulinum Toxine
• Phosphatidylcoline• Hyaluronic Acid
• NO IRRITATIONS, BURNINGS OR INFLAMMATIONS
POWER SUPPLY: 9 V DC, 1A max, externalAVERAGE PULSE CURRENT:
+/-1 mA, 2 mA, 3 mA, 4 mA, 5 mA, user selectable, 20%LOAD IMPEDANCE:0 -15 KOhmPULSE FREQUENCY:2200 Hz
CLASS (ACCORDING TO EN60601-1):Class I type BF
SUPPLY VOLTAGE: 240VC single phaseFREQUENCY: 50 HzPOWER ABSORPTION : 440VA FUSES: 2 x 2 AT at 220V, 50Hz
EXTN CONNECTOR:9Vdc 1A maxCOMPRESSION: 2,5 bar max, adjustableSUCTION POWER:from 0.2 to 0.7 bar (below 10000 mt altitude)
ABRADING MEDIA:High purity medical grade corundum powder
is a new named and patented proprietary technology
Dermoelectroporation® technology utilizes the skin’s water based “channels” to
allow ionic dug solutions to penetrate due to controlled “electroporation-like”
continuous reversed polarity electrical pulses delivery. These pulses increase
the skin permeability and allow transdermal delivery of drugs as occurs in tra-
ditional Ionthophoresis, even if the average current value on the patient is zero.
ttio email@example.com Due to this either micro-molecules and macro-molecules (greater than 800
Kdalton in size, such as Hyaluronic, Vitamins, Amino acids, Heparin,
Antinflammatories etc) are safely delivered into the body without either mod-
ification of the ionic drug solutions pH and Electrolysis effect of the ionic solu-
tion itself. This was not possible with traditional Ionthophoresis systems before.
C-169 Naraina Industrial Area Phase-1, New Delhi - 110028 (India)
Ph.: +91-11-45673300, 25794065 Fax: +91-11-25794064
Customer Care: +91-9311758904 firstname.lastname@example.org I www.timpac.in
ULTRAPEEL II PLUS TRANSDERM MESO Data sheet 55002050 Rev 1.0 Mattioli Engineering Copyright - All rights reserved.
DIAGNOSTIC TRACKS AND TRICKS FOR SEIZURES: DIAGNOSIS AND CLASSIFICATION Tracey A. Milligan, MD, MS Introduction Epileptic seizures are a common medical problem. Ten percent of the population will have one seizure and the cumulative lifetime incidence of epilepsy is 3 percent.1 In the United States, approximately 2.5 million people have epilepsy. Epilepsy affects people of every
Contents Abbreviations Preface Acknowledgements 1. Major primary prevention trials with statins West Of Scotland Coronary Prevention Study (WOSCOPS) Air Force/Texas Coronary Atherosclerosis Prevention Study Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial—Lipid-Lowering Trial (ALLHAT—LLT)PROspective Study of Pravastatin in the Elderly at R